Stay updated on Mite Allergy Treatment Clinical Trial
Sign up to get notified when there's something new on the Mite Allergy Treatment Clinical Trial page.

Latest updates to the Mite Allergy Treatment Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA consolidated Locations section was added to the study page, listing Florida, Georgia, Michigan, Pennsylvania, and Texas. The individual state location entries were removed from the previous layout.SummaryDifference0.4%

- Check24 days agoChange DetectedPublications section updated: added the full citation for 'SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic Asthma: A Randomised Phase III Trial' (Allergy 2025 Dec;80(12):3401-3411; doi:10.1111/all.70073; Epub 2025 Oct 9). The previous 'Online ahead of print' entry for the article was removed.SummaryDifference0.0%

- Check39 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed, and the revision label changes from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoved the government funding lapse notice banner from the page. The main study details and links remain unchanged.SummaryDifference0.2%

- Check68 days agoChange DetectedNew results have been posted for NCT03654976, and study record dates updated to reflect results posting. The Publications section now includes a 2025 article related to the MAPIT trial.SummaryDifference0.3%

- Check82 days agoChange DetectedAdded a new Publications entry from PubMed detailing a randomized Phase III trial on SQ House Dust Mite Sublingual Immunotherapy in children with allergic asthma; no deletions observed.SummaryDifference2%

Stay in the know with updates to Mite Allergy Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mite Allergy Treatment Clinical Trial page.